Antimicrobial activity of tigecycline and comparative agents against clinical isolates of staphylococci and enterococci from ICUs and general hospital wards at three Swedish university hospitals
Authors:
- Carina ClaessonCCCarina Claesson
- Lennart E. NilssonLNLennart E. Nilsson
- Göran KronvallGKGöran Kronvall
- Mats WalderMWMats Walder
- Mikael SörbergMSMikael Sörberg
- 1 January 2009
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 41 (3) , 171-181
Abstract
The activities of tigecycline and comparative agents on staphylococci and enterococci isolated from patients at general hospital wards (GHWs) and intensive care units (ICUs) at 3 university hospitals in Sweden were investigated. Oxacillin disc diffusion and minimal inhibitory concentration with E-test were used. The presence of mecA, vanA or vanB genes was determined with PCR. Statistically significant higher incidence of clindamycin, fusidic acid, rifampicin and multidrug-resistant CoNS was found at ICUs compared to GHWs. Resistance rates were low among S. aureus. Tigecycline, linezolid and vancomycin were the only agents with high activity against methicillin-resistant S. aureus and multidrug-resistant CoNS. Resistance rates were low among E. faecalis, except for high-level gentamicin-resistant (HLGR) E. faecalis. E. faecium showed high resistance rates to ampicillin, piperacillin/tazobactam and imipenem. The HLGR rates among E. faecium were lower than the rates for E. faecalis. Tigecycline and linezolid were the only drugs with high activity against all enterococci including vancomycin-resistant enterococci. No statistically significant differences in susceptibility rates were found between the ward levels for S. aureus and enterococcal isolates and no statistically significant differences were found between the hospitalsKeywords
This publication has 31 references indexed in Scilit:
- Validation and Reproducibility Assessment of Tigecycline MIC Determinations by EtestJournal of Clinical Microbiology, 2007
- Susceptibility of staphylococci and enterococci to antimicrobial agents at different ward levels in four north European countriesScandinavian Journal of Infectious Diseases, 2007
- Functional, Biophysical, and Structural Bases for Antibacterial Activity of TigecyclineAntimicrobial Agents and Chemotherapy, 2006
- Tigecycline MIC Testing by Broth Dilution Requires Use of Fresh Medium or Addition of the Biocatalytic Oxygen-Reducing Reagent Oxyrase To Standardize the Test MethodAntimicrobial Agents and Chemotherapy, 2005
- Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unitDiagnostic Microbiology and Infectious Disease, 2005
- In vitro evaluation of tigecycline and comparative agents in 3049 clinical isolates: 2001 to 2002Diagnostic Microbiology and Infectious Disease, 2005
- Determining incidence of extended spectrum β-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001–2002International Journal of Antimicrobial Agents, 2004
- Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance ProgrammeJournal of Antimicrobial Chemotherapy, 2004
- Activities of the Glycylcycline Tigecycline (GAR-936) against 1,924 Recent European Clinical Bacterial IsolatesAntimicrobial Agents and Chemotherapy, 2003
- Susceptibility of Gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolidJournal of Antimicrobial Chemotherapy, 2000